Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
80 hedge funds and large institutions have $74.8M invested in Singular Genomics Systems, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 12 closing their positions.
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
8% more funds holding
Funds holding: 74 → 80 (+6)
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
25% less capital invested
Capital invested by funds: $99.2M → $74.8M (-$24.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$529K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$482K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$379K |
| 4 |
State Street
Boston,
Massachusetts
|
+$172K |
| 5 |
E
Ergoteles
New York
|
+$152K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$2.23M |
| 2 |
DM
Deerfield Management
New York
|
-$1.4M |
| 3 |
KeyBank National Association
Cleveland,
Ohio
|
-$885K |
| 4 |
PA
Perceptive Advisors
New York
|
-$567K |
| 5 |
BlackRock
New York
|
-$430K |
OMIC Hedge Fund Activity: Q4 2022 in Review
80 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q4 2022, worth a combined $74.8M — down 25% from $99.2M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new OMIC positions and 12 closed out — a net gain of 7 holders — while 23 added to existing stakes and 21 trimmed.
The largest buyer was Vanguard Group, adding an estimated $529K. The largest seller was Tikvah Management, cutting an estimated $2.23M.
- 80 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q4 2022, up from 74 in Q3 2022.
- Funds reported $74.8M of Singular Genomics Systems, Inc. Common Stock stock for Q4 2022, down 25% quarter-over-quarter.
- 19 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q4 2022 and 12 closed out, a net change of +7 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q4 2022 was Vanguard Group, an estimated $529K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q4 2022 was Tikvah Management, an estimated $2.23M sold.
Based on aggregated 13F filings for Q4 2022.